Mark Pacala L.'s most recent trade in Oncology Institute Inc (The) was a trade of 46,296 Common Stock done . Disclosure was reported to the exchange on Nov. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 46,296 | 221,267 | - | 0 | Common Stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 35,494 | 256,761 | - | 0 | Common Stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 18 Nov 2025 | 46,630 | 174,971 | - | 4 | 186,520 | Common Stock |
| Oncology Institute Inc | Mark L. Pacala | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 18 Nov 2025 | 2,160 | 222,811 | - | 4 | 8,640 | Common Stock |
| Oncology Institute Inc | Mark L. Pacala | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 18 Nov 2025 | 1,210 | 221,601 | - | 4 | 4,840 | Common Stock |
| Oncology Institute Inc | Mark L. Pacala | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 26 Mar 2025 | 90,562 | 224,971 | - | 1.0 | 94,338 | Common Stock |
| Oncology Institute Inc | Mark L. Pacala | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2025 | 42,281 | 42,281 | - | - | Common Warrant | |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 50,000 | 134,409 | - | 0 | Common stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 30,372 | 84,409 | - | 0 | Common stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 20,248 | 114,781 | - | 0 | Common stock | |
| Oncology Institute Inc | Mark Pacala L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 46,630 | 135,029 | - | 0 | Common stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 6,562 | 88,399 | - | 0 | Common stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 29,057 | 81,837 | - | 0 | Common Stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 2,160 | 52,780 | - | 0 | Common Stock |